Top Tweets for #Celldex
$CLDX MS ("Overweight", PT $43) after Q2 earnings - #Celldex reiterated clinical timelines for 2H25 and cash guidance through 2027. Plans for a global Ph3b LTE study in CSU; global Ph3 program for CIndU slated to start in 2H25. (I own shares) $REGN
$CLDX doing well. As I mentioned before: Huge interest in #KIT inhibition - $BPMC $DCPH taken out. #Celldex could be the next target, multiple opportunities in the KIT space (Discl. I own shares) https://t.co/Ex53hyQYk1
$CLDX - clear leader- winner with $JSPR debacle - major dilution coming there - if and only if they can get there crap together - sure $JSPR rebounded some after it lost what 80% of its value - much better biotechs to be in & mgt teams
🚨 Celldex Therapeutics drops 19.56% after presenting 52-week Barzolvolimab Phase 2 results at EADV 2024. 📉 Shares now at 32.97. #Celldex #Stocks #Biotech #MarketUpdates
Source: https://t.co/txAmWDbUl3
Just published in Science 🙂🌿🌲🌍🌏🌎
We included sites in the Burrishoole catchment @MarineInst as part of this global #Celldex project led by Scott Tiegs., to estimate and hence predict decomposition rates in streams
https://t.co/qUx0Oe81Q6
Happy to be part of this new publication @ScienceMagazine We use the #Celldex data to highlight human drivers of decomposition rates in rivers at a global scale. We also confirm that the assay used is a strong predictor of actual leaf decomposition #CSA https://t.co/dN4zwSw22t
Celldex is set to present the Phase 2 results of #Barzolvolimab in Chronic Spontaneous #Urticaria at AAAAI 2024. Stay tuned for the latest updates! #Celldex #UrticariaResearch https://t.co/K4OcWVKa8v
A bit blurry, but you can see how cool the global map of carbon processing potential is - generated via the latest #CELLDEX analyses by @CostelloLab and Scott Tiegs et al. CPP using the CSA was strongly predictive of variation in global litter breakdown rates (33% expld) #SFS2023
The latest installment of the #CELLDEX globally replicated study is formatted and available OA. Read how the versatile Cotton Strip Assay was used to measure nutrient uptake in 100 paired stream and riparian sites across 11 biomes @CostelloLab @ScottTiegs https://t.co/QgR7aSDJ7d
New paper! Second product from the #CELLDEX team. We show how N and P drive litter decomp in rivers across the globe. Also, climate impacts on decomp may differ dramatically across the riparian-stream boundary. Read for free! @ScottTiegs @kentbiology https://t.co/x6nqS90XEZ
A good start to the day - I received an update that the latest #CELLDEX paper has been accepted. With two other manuscripts under review, here's hoping the good news continues
#Celldex 社は、いくつかのがん領域での失敗の後、自己免疫疾患に挑戦し、市場はそれを気に入ったようだ。比較的新しいパイプライン #KITチロシンキナーゼ抗体 #CDX0159 が、蕁麻疹患者の100％を寛解させたことを���唆する結果が出た。
https://t.co/WdzikPFrd8
#エバリュエート
Celebrating submission of a paper that was years in the works with the appropriate glassware. @ScottTiegs #CELLDEX
Comeback Kid: $CLDX up 40%++ a/h. My colleague @StephenPHansen spoke with #Celldex's CEO and CSO moments before going into pre #euro2020 final lockdown. #EAACI2021 🏴🇮🇹
The latest revival of 38-yr-old $CLDX comes on the back of urticaria program CDX-0159, with Ph Ib data presented at #EAACI2021 showing 95% complete response rate. @StephenPHansen speaks with #Celldex CEO Anthony Marucci and CSO Tibor Keler https://t.co/2hlZAvIvLl
The latest revival of 38-yr-old $CLDX comes on the back of urticaria program CDX-0159, with Ph Ib data presented at #EAACI2021 showing 95% complete response rate. @StephenPHansen speaks with #Celldex CEO Anthony Marucci and CSO Tibor Keler https://t.co/2hlZAvIvLl
In the afternoon, myself, PhD student Jordyn Stoll and UG @AnthonyP321 will present in the Beyond Breakdown: Detrital nutrient dynamics in freshwaters session. I'll be talking about nutrients and the #CELLDEX project @ScottTiegs
$CLDX Phase 2 A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma…NCT03254927. Estimated Primary Completion Date - 10/2020
$CLDX Celldex Therapeutics Initiates Phase 1 Study of New Bispecific Product Candidate CDX-527 in Solid Tumors => https://t.co/7biVB9BBFj
#Celldex #Biotechnology #BioTech #Stock #CLDX
Celldex opens enrollment for Phase 1 study of solid tumors: CDX-527 candidate
https://t.co/yEGIhK0Ba8
$CLDX #celldex #investingvisualbriefing #smallcap #biotech #phase1 #stocks #infographic #investing
$CLDX Celldex Therapeutics's Price Target raised by Cantor Fitzgerald to $18.00. overweight rating => https://t.co/aaOpeo1AFO
#Celldex #Biotechnology #BioTech #Stock #CLDX
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.6M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
110.4M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.6M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
90.9M followers
KATY PERRY
@katyperry
87.6M followers
Taylor Swift
@taylorswift13
81.4M followers
Lady Gaga
@ladygaga
72.9M followers
Kim Kardashian
@kimkardashian
69.7M followers
Virat Kohli
@imvkohli
69.7M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
63.8M followers
Neymar Jr
@neymarjr
62.5M followers
The Ellen Show
@theellenshow
62.5M followers
CNN
@cnn
61.9M followers
X
@x
60.8M followers
Selena Gomez
@selenagomez
60.6M followers